A recent article in the Washington Post ("Gilead AIDS Drug Shows Prevention Promise") heralds promising new scientific results that use of an anti-retroviral drug among healthy people may prevent transmission of HIV/AIDS. Trials in monkeys showed complete protection despite repeated exposure to HIV over the course of more than three months, and according to the article "if larger tests show the drugs work, they could be given to people at highest risk of HIVâ€”from gay men in American cities to women in Africa who catch the virus from their partners."
CGD Policy Blogs
The New York Times today describes the progress being made in the defeat of Guinea worm.
Now, thanks to a relentless 20-year campaign led by former President Jimmy Carter, Guinea worm is poised to become the first disease since smallpox to be pushed into oblivion. Fewer than 12,000 cases were found last year, down from 3 million in 1986.
Today's Economist has an article about Advance Market Commitments which describes criticisms of the idea by Oxford economist, Andrew Farlow. (The full text of the Economist article is below).
The article mentions three of Dr Farlow's concerns:
- that the terms might create an incentive for less effective vaccines
- that drugs companies might use bribes to increase their share of the valuable market
- that the promise of future purchases might not be credible
According to the Malaysian National News Agency, the WHO said today that
... it will probably take another seven years before a dengue vaccine which is safe and effective against all four strains of the dengue virus can be produced, an expert said ahead of a World Health Organisation's (WHO) Dengue Prevention and Control in Asia Pacific Conference in Chiang Mai.